A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

Not specified

Conditions
Mycobacterium Avium-Intracellulare InfectionHIV Infections
Interventions
DRUG

Rifabutin

Trial Locations (22)

10014

Chelsea Village Med Ctr / Saint Vincent's Hosp, New York

11554

Nassau County Med Ctr, East Meadow

20422

Veterans Administration Med Ctr, Washington D.C.

22203

Infectious Disease Physicians Inc, Annandale

29204

Dr Alfred F Burnside Jr, Columbia

30076

Infectious Disease Research Consortium of Georgia, Atlanta

33021

Mem Hosp Hollywood, Hollywood

33125

Miami Veterans Administration Med Ctr, Miami

33308

TheraFirst Med Ctrs Inc, Fort Lauderdale

33316

Ctr for Special Immunology, Fort Lauderdale

53226

Milwaukee County Med Complex, Milwaukee

55455

Dr Frank Rhame, Minneapolis

64132

Research Med Ctr, Kansas City

85010

Maricopa County Med Ctr, Phoenix

90028

Southwest Community Based AIDS Treatment Group - COMBAT, Los Angeles

90710

Bay Harbor Hosp, Harbor City

92102

HIV Research Group, San Diego

92718

Ctr for Special Immunology, Irvine

94063

AIDS Community Research Consortium, Redwood City

94114

Davies Med Ctr, San Francisco

94121

San Francisco Veterans Administration Med Ctr, San Francisco

071032842

North Jersey Community Research Initiative, Newark

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pharmacia

INDUSTRY

NCT00001995 - A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS | Biotech Hunter | Biotech Hunter